CompaniesVascular Magnetics

Vascular Magnetics

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (72)

View all

Total Trials

As Lead Sponsor

As Collaborator

Total Enrollment

59,190

By Phase

NA: 47PHASE3: 1PHASE4: 8PHASE1: 3PHASE1/PHASE2: 1

By Status

COMPLETED: 53RECRUITING: 5ACTIVE_NOT_RECRUITING: 4UNKNOWN: 3TERMINATED: 3NOT_YET_RECRUITING: 2WITHDRAWN: 2

Clinical Trials Pipeline72 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

2030

2031

2032

Today

NCT00614848

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions

Phase: N/A

Role: Lead Sponsor

Start: Jun 30, 2003

Completion: Jul 31, 2009

NCT00614848

NCT00217256

The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial

Phase: N/A

Role: Lead Sponsor

Start: Feb 29, 2004

Completion: Dec 31, 2010

NCT00217256

NCT00217269

The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions

Phase: N/A

Role: Lead Sponsor

Start: Apr 30, 2005

Completion: Jul 31, 2011

NCT00217269

NCT00248079

The Medtronic RESOLUTE Clinical Trial

Phase: Phase 1/2

Role: Lead Sponsor

Start: Nov 30, 2005

Completion: Oct 31, 2011

NCT00248079

NCT00314275

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2006

Completion: Aug 31, 2011

NCT00314275

NCT01067885

A Post-market Registry of the MARIS-stent (Invatec) Implanted in the Superficial Femoral Artery

Phase: N/A

Role: Collaborator

Start: Apr 30, 2006

Completion: Dec 31, 2009

NCT00693030

Optical Coherence Tomography for Drug Eluting Stent Safety

Phase: Phase 4

Role: Collaborator

Start: Aug 31, 2006

Completion: Dec 31, 2008

NCT00418067

Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions

Phase: Phase 4

Role: Collaborator

Start: Oct 31, 2006

Completion: Jan 31, 2009

NCT00476957

Randomized Study Comparing Endeavor With Cypher Stents (PROTECT)

Phase: Phase 4

Role: Lead Sponsor

Start: Jun 30, 2007

Completion: Jul 31, 2014

NCT00476957

NCT00483808

Renal Denervation in Patients With Refractory Hypertension

Phase: Phase 1

Role: Lead Sponsor

Start: Jun 30, 2007

Completion: May 31, 2013

NCT00483808

NCT00551304

Native Kidney Denervation in Patients With End Stage Renal Disease

Phase: Phase 1

Role: Lead Sponsor

Start: Oct 31, 2007

Completion: Not specified

NCT00551304

NCT00793312

China Endeavor Registry: A Registry With The Endeavor Zotarolimus Eluting Coronary Stent in China

Phase: N/A

Role: Lead Sponsor

Start: Nov 30, 2007

Completion: Sep 30, 2010

NCT00609947

Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2008

Completion: Sep 30, 2013

NCT00609947

NCT00607321

Bare Metal Bifurcation Stent Clinical Trial in Humans

Phase: N/A

Role: Lead Sponsor

Start: Feb 29, 2008

Completion: Aug 31, 2010

NCT00617084

Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent

Phase: Phase 4

Role: Lead Sponsor

Start: Apr 30, 2008

Completion: Feb 28, 2014

NCT00617084

NCT00664638

Renal Denervation in Patients With Refractory Hypertension

Phase: N/A

Role: Lead Sponsor

Start: Apr 30, 2008

Completion: May 31, 2013

NCT00664638

NCT01133925

Optical Coherence Tomography in Long Lesions

Phase: Phase 4

Role: Collaborator

Start: May 31, 2008

Completion: May 31, 2011

NCT00726453

The Medtronic RESOLUTE US Clinical Trial

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2008

Completion: Mar 31, 2016

NCT00726453

NCT00752128

RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population

Phase: N/A

Role: Lead Sponsor

Start: Aug 31, 2008

Completion: Dec 31, 2012

NCT00753116

Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

Phase: Phase 1

Role: Lead Sponsor

Start: Sep 30, 2008

Completion: Dec 31, 2009

NCT00753285

Renal Denervation in Patients With Refractory Hypertension

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2008

Completion: May 31, 2013

NCT00753285

NCT00894062

Comparison of Neointimal Coverage Between Zotarolimus Eluting Stent and Everolimus Eluting Stent

Phase: Phase 4

Role: Collaborator

Start: Dec 31, 2008

Completion: Not specified

NCT00894062

NCT00846846

PROTECT Continued Access Post Marketing Surveillance Trial

Phase: Phase 4

Role: Lead Sponsor

Start: Jan 31, 2009

Completion: Mar 31, 2015

NCT00846846

NCT00927940

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent

Phase: N/A

Role: Lead Sponsor

Start: Mar 31, 2009

Completion: Feb 28, 2015

NCT00927940

NCT00888433

Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)

Phase: N/A

Role: Lead Sponsor

Start: Jun 30, 2009

Completion: May 31, 2015

NCT00888433

NCT00961311

Sprinter Legend Balloon Catheter

Phase: N/A

Role: Lead Sponsor

Start: Aug 31, 2009

Completion: Jan 31, 2010

NCT01069003

EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events

Phase: Phase 4

Role: Lead Sponsor

Start: Apr 30, 2010

Completion: Apr 30, 2014

NCT01132456

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia

Phase: N/A

Role: Lead Sponsor

Start: Jun 30, 2010

Completion: Apr 30, 2016

NCT01132456

NCT01150500

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries

Phase: N/A

Role: Lead Sponsor

Start: Jun 30, 2010

Completion: Jun 30, 2016

NCT01150500

NCT01219894

Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Therapy After Drug Eluting Stent Placement

Phase: N/A

Role: Collaborator

Start: Nov 30, 2010

Completion: Dec 31, 2010

NCT01243749

RESOLUTE China Registry:

Phase: N/A

Role: Lead Sponsor

Start: Dec 31, 2010

Completion: Dec 15, 2017

NCT01243749

NCT01297257

DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER Stenting

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2011

Completion: Apr 30, 2013

NCT01334268

RESOLUTE China RCT

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2011

Completion: Jun 30, 2017

NCT01334268

NCT01418261

SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2011

Completion: Feb 17, 2017

NCT01418261

NCT01392196

Renal Denervation in Patients With Chronic Heart Failure & Renal Impairment Clinical Trial

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2011

Completion: Jun 30, 2016

NCT01392196

NCT01552109

Stable Angina Observational Registry

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2012

Completion: Dec 31, 2013

NCT01534299

Global SYMPLICITY Registry (GSR) DEFINE

Phase: N/A

Role: Lead Sponsor

Start: Feb 29, 2012

Completion: Dec 31, 2031

NCT01534299

NCT01638507

An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2012

Completion: Jun 30, 2015

NCT01644604

Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2012

Completion: Jun 30, 2017

NCT01644604

NCT01699529

Multi-electrode Radiofrequency Renal Denervation System Feasibility Study

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2012

Completion: Oct 31, 2016

NCT01808391

A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL)

Phase: N/A

Role: Collaborator

Start: Mar 31, 2013

Completion: Apr 30, 2016

NCT01913600

Resolute Integrity US Extended Length Sub-Study(RI US XL)

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2013

Completion: Dec 31, 2018

NCT01913600

NCT01632943

Single-arm Study of Symplicity™ Renal Denervation System in Patients With Uncontrolled HyperTensioN in India

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2013

Completion: Dec 31, 2014

NCT01972139

Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2013

Completion: Jan 31, 2017

NCT02086019

Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes

Phase: N/A

Role: Collaborator

Start: May 1, 2014

Completion: Dec 12, 2019

NCT02086019

NCT02064764

Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2015

Completion: Apr 19, 2021

NCT02064764

NCT02412501

Medtronic Resolute Onyx 2.0 mm Clinical Study

Phase: N/A

Role: Lead Sponsor

Start: Apr 6, 2015

Completion: Feb 21, 2019

NCT02452736

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Phase: Phase 3

Role: Lead Sponsor

Start: May 31, 2015

Completion: Dec 31, 2015

NCT02439749

SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study

Phase: N/A

Role: Lead Sponsor

Start: Jun 30, 2015

Completion: Oct 25, 2023

NCT02439749

NCT02419521

Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study

Phase: N/A

Role: Lead Sponsor

Start: Jul 7, 2015

Completion: Dec 3, 2018

NCT02439775

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2015

Completion: Sep 28, 2025

NCT02439775

NCT02480348

Medtronic RevElution Trial

Phase: N/A

Role: Lead Sponsor

Start: Dec 3, 2015

Completion: Oct 21, 2019

NCT03063749

RESOLUTE ONYX Post-Approval Study

Phase: N/A

Role: Lead Sponsor

Start: Mar 30, 2017

Completion: Aug 18, 2022

NCT03063749

NCT03118531

China Resolute Integrity 34/38 mm Study

Phase: N/A

Role: Lead Sponsor

Start: Apr 17, 2017

Completion: Apr 28, 2023

NCT03118531

NCT02939976

Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)

Phase: N/A

Role: Collaborator

Start: Aug 30, 2017

Completion: Jul 19, 2023

NCT02939976

NCT03260517

The PREVAIL Study

Phase: N/A

Role: Lead Sponsor

Start: Oct 2, 2017

Completion: Aug 1, 2019

NCT03344653

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients

Phase: N/A

Role: Lead Sponsor

Start: Nov 2, 2017

Completion: Oct 9, 2020

NCT03471845

RESOLUTE ONYX China Single Arm Study

Phase: N/A

Role: Lead Sponsor

Start: Mar 30, 2018

Completion: Oct 2, 2025

NCT03471845

NCT03466151

RESOLUTE ONYX China RCT Study

Phase: N/A

Role: Lead Sponsor

Start: Apr 12, 2018

Completion: Sep 19, 2025

NCT03466151

NCT03584464

RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)

Phase: N/A

Role: Lead Sponsor

Start: May 14, 2018

Completion: Sep 28, 2022

NCT03647475

A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)

Phase: N/A

Role: Lead Sponsor

Start: Oct 1, 2018

Completion: Apr 22, 2021

NCT03738124

Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Thoracic Aortic Aneurysms and Chronic Dissections

Phase: N/A

Role: Collaborator

Start: Jan 31, 2019

Completion: Feb 28, 2026

NCT03738124

NCT04011371

Cyanoacrylate Closure for Treatment of Venous Leg Ulcers

Phase: N/A

Role: Collaborator

Start: Sep 1, 2019

Completion: Jun 1, 2022

NCT04146168

Lake Washington Vascular VenaSeal™ Post-Market Evaluation

Phase: N/A

Role: Collaborator

Start: Nov 30, 2019

Completion: Mar 31, 2020

NCT04311086

SPYRAL DYSTAL Renal Denervation Global Clinical Study

Phase: N/A

Role: Lead Sponsor

Start: Jun 12, 2020

Completion: Dec 22, 2022

NCT05198674

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Phase: N/A

Role: Lead Sponsor

Start: Oct 20, 2021

Completion: Nov 30, 2029

NCT05198674

NCT06535854

Prevail Global Study

Phase: N/A

Role: Lead Sponsor

Start: Feb 24, 2025

Completion: Feb 28, 2031

NCT06535854

NCT06907147

SPYRAL GEMINI Pilot Study

Phase: N/A

Role: Lead Sponsor

Start: May 1, 2025

Completion: Dec 22, 2029

NCT07013929

Spyral InSight Study

Phase: N/A

Role: Lead Sponsor

Start: Jun 9, 2025

Completion: Jul 1, 2027

NCT07115953

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

Phase: N/A

Role: Lead Sponsor

Start: Aug 27, 2025

Completion: Dec 31, 2029

NCT07174622

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2025

Completion: Jun 30, 2029

NCT07081243

Symplicity China Study

Phase: N/A

Role: Lead Sponsor

Start: Nov 4, 2025

Completion: Dec 30, 2031

NCT07081243

Hover over trial bars to see details

Recent Trials

NCT07081243Lead Sponsor

Symplicity China Study

N/ANot yet recruiting

500 participants

Started: Nov 4, 2025 · Completed: Dec 30, 2031

NCT07174622Lead Sponsor

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

N/ANot yet recruiting

1,000 participants

Started: Oct 31, 2025 · Completed: Jun 30, 2029

NCT07115953Lead Sponsor

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

NARecruiting

130 participants

Started: Aug 27, 2025 · Completed: Dec 31, 2029

NCT07013929Lead Sponsor

Spyral InSight Study

NARecruiting

19 participants

Started: Jun 9, 2025 · Completed: Jul 1, 2027

NCT06907147Lead Sponsor

SPYRAL GEMINI Pilot Study

NARecruiting

175 participants

Started: May 1, 2025 · Completed: Dec 22, 2029

View all 72 trials →